Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Berlin - Delayed Quote EUR

Altimmune Inc (3G0.BE)

4.4110
+0.1710
+(4.03%)
At close: 9:52:10 PM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
20
20
426
-68
4,410
Operating Expense
103,192
103,192
83,936
87,672
89,954
Operating Income
-103,172
-103,172
-83,510
-87,740
-85,544
Net Non Operating Interest Income Expense
8,065
8,065
7,316
2,862
198
Other Income Expense
48
48
-12,253
-32
-11,744
Pretax Income
-95,059
-95,059
-88,447
-84,910
-97,090
Tax Provision
--
--
--
-197
--
Net Income Common Stockholders
-95,059
-95,059
-88,447
-84,713
-97,090
Diluted NI Available to Com Stockholders
-95,059
-95,059
-88,447
-84,713
-97,090
Basic EPS
-1.57
-1.34
-1.66
-1.81
-2.35
Diluted EPS
-1.57
-1.34
-1.66
-1.81
-2.35
Basic Average Shares
67,820.3860
71,003.3990
53,246.9370
46,926.3490
41,283.4980
Diluted Average Shares
67,820.3860
71,003.3990
53,246.9370
46,926.3490
41,283.4980
Total Operating Income as Reported
-103,172
-103,172
-95,929
-87,740
-96,914
Total Expenses
103,192
103,192
83,936
87,672
89,954
Net Income from Continuing & Discontinued Operation
-95,059
-95,059
-88,447
-84,713
-97,090
Normalized Income
-95,059
-95,059
-76,028
-84,713
-85,720
Interest Income
8,074
8,074
7,351
2,870
203
Interest Expense
9
9
35
8
5
Net Interest Income
8,065
8,065
7,316
2,862
198
EBIT
-95,050
-95,050
-88,412
-84,902
-97,085
EBITDA
-94,812
-94,812
-87,935
-84,409
-96,534
Reconciled Depreciation
238
238
477
493
551
Net Income from Continuing Operation Net Minority Interest
-95,059
-95,059
-88,447
-84,713
-97,090
Total Unusual Items Excluding Goodwill
--
--
-12,419
--
-11,370
Total Unusual Items
--
--
-12,419
--
-11,370
Normalized EBITDA
-94,812
-94,812
-75,516
-84,409
-85,164
Tax Rate for Calcs
--
--
--
0
--
12/31/2021 - 3/26/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PH4.DU CStone Pharmaceuticals
0.3220
+5.92%
 
2VSA.DU Verastem Inc. R
6.35
+6.72%
 
IMR.SG AC Immune SA
1.3560
+6.27%
 
473A.SG Adaptimmune Therapeutics PLC
0.2260
+2.73%
 
F6T.SG Fate Therapeutics Inc
1.1970
+1.57%
 
MDG1.F Medigene AG
0.2190
+30.36%
 
TBPH Theravance Biopharma, Inc.
9.45
+1.50%
 
OCS Oculis Holding AG
17.89
+0.62%
 
VOR Vor Biopharma Inc.
0.7591
+8.13%
 
SCPH scPharmaceuticals Inc.
2.6000
-0.38%